Trial Profile
Retrospective analysis of Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2018
Price :
$35
*
At a glance
- Drugs Pomalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 31 Aug 2018 New trial record